genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2021
Theravance Biopharma
Coronavirus
After Clinical Setbacks, Theravance Axes 75% of Workforce and Refocuses on Respiratory Drugs
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Podcasts
Virtual Collaborations Push Pharma Forward During Pandemic
Drug Discovery
Takeda Licenses COUR’s Celiac Disease Candidate after Successful Phase IIa Trial
Industry News
Takeda to Develop Theravance’s EFI Candidate TD-8954
News
Firms Partner on Gastroparesis Drug
Drug Discovery
GSK, Theravance Report Mixed Bag of Data for Relovair in COPD, Asthma
Scroll Up